reviewTop 1% cited
The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis
European Urology · 2008 · Vol. 54(3) · pp. 543–562
Christopher R. Chapple✉(Royal Hallamshire Hospital)Vik Khullar(St Mary's Hospital)Zahava GabrielDominic MustonCaty Ebel Bitoun(Pfizer (France))David Weinstein(Pfizer (France))
Urinary Bladder and Prostate ResearchPelvic floor disorders treatmentsUrinary Tract Infections ManagementTolerabilityMedicineOveractive bladderOxybutyninTolterodinePlaceboAdverse effectSolifenacinAnticholinergicUrology
MeSH terms
HumansQuality of LifeRandomized Controlled Trials as TopicMuscarinic AntagonistsUrinary Bladder, Overactive
Citations
763
FWCI
58.58
field-weighted impact
References
44
Percentile
100%
vs. same field & year
Citations per year
Cited by
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
The Journal of Urology · 2012 · 699 citations
References
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder
Urology · 2001 · 459 citations
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
British Journal of Pharmacology · 2006 · 629 citations
Systematic Reviews in Health Care. Meta-analysis in Context.
International Journal of Epidemiology · 2002 · 1,371 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.